A drug company is conducting a clinical trial of a procedure that they hope will help patients who have taken but now stopped taking tirzepatide keep the weight off
Another interesting search statistic is that the search frequency for related terms has actually picked up momentum between November 2020 and June 2021, peaking at 75%
55:40 - Raza discusses the latest Texas A&M study [7-10] The researchers compared caffeine to paraxanthine -- while there were some speed components to caffeine, there were fewer mistakes with paraxanthine
The goal of "fibermaxxing" is to meet or exceed your daily fiber intake of 25-38 grams for adults
50 A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults with Obesity (SURMOUNT-MMO) is due for completion in 2027 (clinical trial number NCT05556512)
These risks include dosing errors, sterility concerns, counterfeit products, altered bioavailability, and reduced clinician oversight in some settings